In the heart of Rochester, Minnesota, the Mayo Clinic stands as a beacon of medical excellence, consistently ranked as the best hospital in the United States and one of the top hospitals globally. Among its distinguished staff is Dr. Juna Musa, a young and brilliant Albanian doctor whose work is garnering international attention.
Dr. Musa’s journey to the Mayo Clinic is a testament to her dedication and expertise. She is a medical doctor and holds a master’s degree in clinical research from the esteemed Erasmus Medical Center in the Netherlands, a credential that underscores her solid foundation in medical research and practice. Her academic and professional trajectory highlights the high standards of medical education and practice in Albania, a country she proudly represents on the global stage.
At the Mayo Clinic, Dr. Musa works in the Department of Interventional Radiology Oncology. This field, at the intersection of cutting-edge technology and clinical expertise, focuses on minimally invasive procedures to diagnose and treat cancers. Dr. Musa’s role is pivotal, involving collaboration with the Philips Innovation Lab in the USA. This partnership is crucial in advancing the integration of innovative imaging technologies and treatment techniques, aiming to improve patient outcomes and push the boundaries of modern oncology.
Advancing Imaging and Treatment Modalities
Her primary focus is on assessing the efficacy of advanced imaging and treatment modalities, particularly those offered by Philips’s portfolio while emphasizing the unique capabilities of the Angio/Spectral C17500 scanner. This technology, spearheaded by Dr. Musa, holds the promise of revolutionizing medical imaging and cancer treatment, especially in the critical areas of identifying tumor margins and ensuring successful ablation procedures with minimal recurrence.
Dr. Musa’s intimate knowledge of the specifications and critical role within the organization underscores her personal, cultural, and professional contributions to the radiology practice at Mayo Clinic. Her work is a testament to the positive impact of diversity and international collaboration within the medical community.
Mayo Clinic is renowned both in the U.S. and worldwide as a leading authority on healthcare and is regularly ranked as the number one hospital both nationally and globally. As a teaching hospital, Mayo Clinic’s core mission is to recruit and educate the next generation of physician leaders. Dr. Musa’s unique position coordinates work between the Department of Radiology and Philips’s Innovation Laboratory, ensuring the progress of projects aimed at achieving the overall objectives of the collaboration.
Innovative Technological Integration
Of particular note is Dr. Musa’s involvement in a groundbreaking project involving the installation and utilization of the world’s first unique Angio/Spectral C17500 scanner by Philips, a technology that holds the potential to revolutionize the field of medical imaging and cancer treatment. This cutting-edge technology is specifically designed for percutaneous thermal ablation on various tumoral masses, representing a significant leap forward in the field of cancer treatment. Notably, this marks the first global launch of such technology by Philips.
As the world’s first of its kind, the Spectral C17500 scanner represents a leap forward in medical imaging technology. Its unique capabilities hold the potential to revolutionize the field of cancer treatment by providing new insights into tumor biology and response to treatment.
.
Enhancing Cancer Treatment with Advanced Imaging
Dr. Musa’s role in evaluating and utilizing this technology is integral to the success of ongoing research projects at Mayo Clinic. Her expertise in MRI-guided procedures and her contributions to pioneering projects demonstrate her commitment to advancing medical imaging and cancer treatment.
Her expertise in utilizing the Spectral C17500 scanner and the Elition 1.5T MRI for percutaneous thermal ablation has shown promising results across different tumoral masses, showcasing the potential for a revolutionary impact on cancer treatment. Her work involves evaluating advanced imaging and treatment modalities, such as the Spectral Angio CT scan and MRI interventions, to develop new approaches for identifying tumor margins and assessing the success of ablation procedures. These efforts contribute to advancing the field of minimally invasive cancer care.
Dr. Musa’s research exhibits remarkable diversity, covering a wide range of tumor types and utilizing novel technologies such as Spectral CT and MRI images in percutaneous ablation of various tumoral masses, including those in the lung, liver, kidney, prostate, soft tissue, and bone.
Innovative Imaging Sequences
One significant aspect of Dr. Musa’s work involves the development and application of innovative imaging sequences, such as the Spiral Staircase Ultrashort Echo Time (UTE) sequence. This sequence allows for real-time temperature visualization during MRI-guided cryoablation of prostate cancer, addressing the limitations of traditional imaging sequences in providing precise temperature measurements, particularly in sub-zero temperature ranges near tumors. By utilizing the UTE sequence for thermometry during cryoablation, Dr. Musa enables real-time quantitative temperature tracking, refining the cryoablation protocol and ensuring accurate visualization of the ice ball formation.
In the field of interventional radiology and oncology, Dr. Musa’s methodology offers a valuable tool for enhancing the efficacy of cryoablation procedures. It enables interventional radiologists to monitor tissue temperature with greater precision, leading to more accurate delivery of thermal doses to tissue lesions. Furthermore, the methodology and findings of Dr. Musa’s research hold broader applications beyond prostate cancer treatment, potentially extending to other fields where thermal ablation procedures are employed, such as liver tumors or cardiac arrhythmias.
Real-World Impact
The practical real-world applications of Dr. Musa’s work are profound, significantly improving patient care and procedural outcomes in cryoablation treatments. Real-time quantitative temperature tracking during cryoablation procedures allows clinicians to optimize thermal dose delivery, ensuring more effective tissue ablation while minimizing damage to surrounding healthy tissue. This enhances treatment efficacy, reduces procedure times, and improves patient safety.
Dr. Musa’s contribution to the field is exceptional due to its innovative approach to addressing a critical need in cryoablation procedures. While previous studies have explored temperature mapping during cryoablation, Dr. Musa’s work significantly advances existing methods by introducing a novel imaging sequence specifically designed for this purpose. Her contribution improves procedural guidance, enhances treatment outcomes, and ultimately benefits patient care by providing clinicians with a more accurate and reliable means of monitoring tissue temperature during cryoablation.
Her substantial contributions to interventional radiology oncology research are noteworthy. Beyond clinical practice, her dedication is evident through her involvement in projects aligned with the United Nations’ Sustainable Development Goals. Dr. Musa’s portfolio includes 14 published scientific works, showcasing her commitment to addressing global challenges through innovative research. Of particular significance, her most recent open-access articles from Elsevier journals were directly linked to advancing sustainable development goals.
In recognition of her exceptional contributions and dedication to advancing medical research and patient care, Dr. Musa was recently honored through the Mayo Clinic Excellence Above and Beyond Recognition Program in 2022. This award underscores her exceptional contributions and dedication to advancing medical research and patients.
Optimizing Imaging Protocols
Another significant aspect of Dr. Musa’s role involves her work in optimizing imaging protocols while ensuring patient safety and diagnostic efficacy. Her study evaluates the use of low monoenergetic spectral CT imaging to enhance the conspicuity of ablation zones following percutaneous cryoablation of renal tumors, particularly when using a reduced contrast dose. This research addresses the clinical need to minimize contrast exposure while maintaining diagnostic accuracy, especially in patients with impaired renal function.
The practical real-world applications of this study’s findings are substantial, providing valuable guidance for optimizing imaging protocols in renal post-ablation assessment. By demonstrating the potential value of low monoenergetic spectral CT imaging in maintaining high-quality imaging with reduced contrast doses, the study enhances patient safety and workflow efficiency in renal post-ablation assessment. Dr. Musa’s contribution improves upon existing methods by demonstrating a practical application of spectral CT imaging in reducing contrast dose while maintaining diagnostic efficacy, thereby enhancing patient care outcomes. Additionally, her contribution to computed diffusion-weighted imaging (DWI) revolutionizes imaging protocols by reducing acquisition time while maintaining image quality, particularly in prostate cancer detection. This innovation streamlines diagnostic processes, improves patient throughput in clinical settings, and has broader applications in neurology and orthopedics, enhancing patient care outcomes across various medical specialties.
Innovative Device for Imaging -Guided Interventions
Dr. Juna Musa’s contribution to developing an innovative device with significant implications for radiology, particularly in imaging-guided interventions and procedures. By leveraging colorimetric capnography technology, which provides objective and accurate assessments of the success of needle decompression, this device enhances the safety and efficacy of procedures such as percutaneous biopsies, ablations, and other minimally invasive interventions performed under imaging guidance.
In radiology, where precision and real-time feedback are crucial, this device offers several advantages. Firstly, it enables radiologists to monitor the effectiveness of needle placements and interventions in real-time, ensuring optimal targeting and minimizing the risk of complications. Additionally, by providing immediate feedback on the success of procedures, the device enhances workflow efficiency and reduces the need for follow-up interventions.
Moreover, the device’s applicability in prehospital settings is particularly relevant in radiology, where emergent procedures may be performed outside of the hospital setting, such as in trauma cases or interventional radiology emergencies. In these situations, the device can aid in the rapid assessment of intervention success, facilitating timely decision-making and improving patient outcomes.
Dr. Juna Musa is a shining example of a medical professional whose work transcends borders. Her contributions at the Mayo Clinic, supported by her rigorous training and innovative collaborations, highlight the significant role of Albanian doctors on the world stage. As she continues to push the frontiers of medical research and treatment, Dr. Musa not only elevates the standards of interventional radiology oncology but also brings pride to her homeland, Albania.